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1. Introduction
Ionizing radiation (IR) and various cytotoxic chemicals including reactive oxygen species
(ROS)  induce  DNA double-strand breaks  (DSBs)  when they  attack  the  phosphate  back‐
bones of  the two DNA strands simultaneously.  DSBs,  once generated,  not  only cause a
discontinuity in the genetic code, but also are vulnerable to further loss of DNA from a
nuclease attack or the formation of abnormal DNA structures from chromosomal translo‐
cation,  all  of  which  can  significantly  increase  genomic  instability  leading to  cancer.  Re‐
pair  of  DSB  damage  is  therefore  crucial  for  maintaining  the  physical  and  genetic
integrity of the genome.
DNA damage sensors are the first responder to various types of DNA damages. Upon DSB
damage, Mre11–Rad50–Nbs1 (MRN) complex initially recognizes DNA damage, and re‐
cruits and activates the ataxia-telangiectasia mutated (ATM) through protein interaction
with Nbs1 (Fig. 1) [1, 2]. ATM is a member of the phosphoinositide 3-kinase (PI3K)-related
protein kinase (PIKK) family of serine/threonine protein kinases that phosphorylates a num‐
ber of target proteins containing conserved phosphorylation motif (SQ/TQ) in response to
DNA damage [3] that include MRN complex, a histone variant, H2AX, a checkpoint media‐
tor, MDC1, a checkpoint kinase, CHK2 and p53 [4]. Phosphorylations of MRN complex,
H2AX and MDC1 are necessary for recruitment of the factors involved in signal transduc‐
tion and homologous recombination (HR) to facilitate the repair process [5-9]. A marginal
repair defect was observed in AT cells, which could be due to the reduced efficiency of ho‐
mologous recombination [10]. Damage-induced phosphorylation of CHK2 and activation of
p53 also induce the cell cycle arrest at the G1 phase [6, 11, 12].
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Figure 1. Three major DSB repair pathways in mammals. Following recognition of DSB damage by MRN complex and
ATM, leading to phosphorylation of H2AX, DSB repair can occur through nonhomologous end joining (NHEJ), homol‐
ogous recombination (HR), or microhomology-mediated end joining (MMEJ) repair pathways. The error-free pathway
of HR in the late S- and G2-phases of the cell cycle requires a sister chromatid to restore broken DNA to its original
sequence, whereas the error-prone pathway of NHEJ often processes the DNA by adding or deleting nucleotides be‐
fore joining the ends. In some circumstances one or more of the broken ends is refractory to Ku mediated NHEJ. In this
case, MMEJ can proceed by nucleolytic processing and resection of the 3’-end until a short region of complimentary
bases is revealed. Pairing of this microhomology stabilizes the broken ends, displaced flaps are removed and ligation
can occur. Although many of the proteins involved in these major DSB repair pathways have been identified, the pre‐
cise mechanisms involved remain poorly understood.
In mammals, DSB damages are largely repaired by non-homologous end joining (NHEJ)
pathway throughout the cell  cycle that  directly ligates the break ends without the need
for a homologous template (Fig. 1), so NHEJ is an error-prone repair pathway. Microho‐
mology-mediated end joining (MMEJ) shares the repair proteins with NHEJ pathway, ex‐
cept  that  it  uses  a  short  patch  (5-25  base  pairs)  of  homologous  sequences  to  align  the
broken strands before joining (Fig. 1).  When a break occurs a homology of 5-25 comple‐
mentary base pairs on both strands is  identified and used as a basis  for which to align
the strands with mismatched ends. Once aligned, any overhang or mismatched bases on
both strands are removed and any missing nucleotides are inserted. MMEJ works by li‐
gating the mismatched hanging strands of DNA, removing overhanging nucleotides and
filling in the missing base pairs. MMEJ repair occurs during the S-phase of the cell cycle,
as  opposed to  the  G0/G1 and early  S  phases  in  NHEJ.  MMEJ ligates  the  DNA strands
without checking for consistency and causes deletions, since it removes base pairs (flaps)
on the strand in order to  align the two pieces;  it  is  an error-prone repair  pathway and
results  in deletion mutations.  In most  cases,  a  cell  uses MMEJ only when the NHEJ re‐
pair  is  not  available  or  unsuitable  due  to  the  disadvantage  posed  by  introducing  dele‐
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tions into the genetic code.  When a sister chromatid is  available during late S-  and G2-
phases of the cell  cycle,  DSB damage can also be repaired by homology-directed repair,
called homologous recombination (HR) (Fig. 1).  This requires extensive 5’-3’  resection of
DNA to generate a 3’ single-stranded tail. This is then displaced by the RAD51 recombi‐
nase,  which forms a  nucleoprotein filament  which invades a  homologous DNA duplex.
This process named strand exchange forms a DNA crossover or Holliday junction which
provides a primer to initiate new DNA synthesis. At this point there can be several out‐
comes.  In  synthesis  dependent  strand  annealing  the  newly  synthesized  DNA  reverts
back to its original partner where it can be used as a template to complete repair. Alter‐
natively  for  homologous  recombination,  the  Holliday  junction  migrates  away  from  the
initial  point  of  exchange (branch migration) until  the junction is  resolved by nucleolytic
cleavage of either the crossed strands or non-crossed strands of the junction.  Resolution
of the two Holliday junctions in different orientations results in the exchange of flanking
markers  (crossover),  whereas  resolution  in  the  same  orientation  does  not  result  in  ex‐
change of flanking markers (non-crossover).
Since NHEJ repair involves a direct rejoining of the separated DNA ends, it requires the
coordinated  assembly  of  damage-responsive  proteins  at  the  damage  site.  DSB  repair
through NHEJ is initiated by binding Ku70-Ku80 complex to the DSB ends (Fig. 2).  The
Ku70/80 complex first binds to the DNA ends and recruits DNA-dependent protein kin‐
ase catalytic subunit (DNA-PKcs), a 465-kDa ser/thr kinase that mediates synapsis of the
ends and then undergoes activation of its kinase. DNA-PKcs is a member of PIKK family
[13],  but  its  contribution  to  checkpoint  response  is  insignificant.  Kinase  activity  is  re‐
quired for NHEJ, but its function remains unclear. Rather, it phosphorylates multiple pro‐
teins involved in NHEJ [14]. Artemis, a nuclease, and PNK, a kinase/phosphatase, process
the ends [15-17], and DNA ligase IV, a complex with XRCC4, ligates two DSB ends (Fig.
2) [18,  19].  The recruitment of the XRCC4-DNA ligase IV (Lig4) complex is essential for
the final step of ligation. XLF (also known as Cernunnos) is known to stimulate Lig4 in
vitro  through its  interaction with  XRCC4.  Although DNA end joining systems in  mam‐
mals are dependent on above-mentioned factors (Ku70/80, DNA-PKcs, and XRCC4/Lig4),
additional factors are required for end processing during NHEJ. Artemis exists in a com‐
plex with DNA-PKcs and has nuclease activity. Mre11 and Artemis possess 3’-5’ and 5’-3’
exonuclease,  respectively,  both  of  which  may  be  involved  in  promoting  the  joining  of
noncomplementary  ends  via  utilizing  microhomologies  near  the  ends  of  the  DSB.  The
Werner syndrome protein (WRN) with its DNA cleavage activity stimulated by Ku com‐
plex  is  also  a  potential  player  in  DNA end processing.  Others  implicated  in  DNA end
processing include FEN-1, PNK, and DNA polymerases μ and λ. In addition, DNA poly‐
merase(s)  are  also  likely  involved  in  the  gap  filling  of  NHEJ  reaction.  Metnase  (also
known as  SETMAR)  is  a  new comer  in  DSB repair  pathways  that  not  only  methylates
histone H3 lysine 36 at DSB sites but also plays several other roles in the joining of DSB
damages.  Although  this  review  discussed  current  issues  on  DSB  repair  in  general,  it
mainly focuses on the emerging roles of Metnase in DSB repair pathway.
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Figure 2. Nonhomologous end joining (NHEJ) repair pathway in mammals. When a DSB is introduced, Ku binds to the
DNA because of its high affinity for DNA ends. The binding of Ku elicits conformational changes that allow it to bind
DNA-PKcs. Ku may also serve as an alignment factor for the accuracy of NHEJ. Upon the assembly of DNA-PK on DNA
breaks, this DNA repair complex activates its serine/threonine protein kinase activity and phosphorylates target sub‐
strates such as Artemis that colocalize at the ends of broken DNA prior to end processing and end joining events.
2. Human SET-Transposase chimeric protein in DSB repair
Transposases mediate DNA movement by recognizing both ends of transposon to excise the
element from one site and insert it at other location in the genome, a process which can be
repeated multiple times for a given segment [20-25]. It is likely that the ends are brought to‐
gether and form a synaptic complex comprising two transposase molecules and the two
ends of the corresponding element [25-28]. While transposase has played an important evo‐
lutionary role accounting for half of the present organization of the human genome [29],
transposase activity was thought to be extinct in humans because unregulated DNA mobili‐
ty could be highly deleterious in a long lived organism. To date, only one example of an in‐
tact copy of the Hsmar1 transposase domain has been identified within the human genome
[30]. The Hsmar1 transposon, a class II transposable element, is an ancient element within
the human genome introduced at least 50 million years ago in ancestral primates [23]. This
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“functional” Hsmar1 transposase domain exists as a chimeric fusion protein, Metnase (also
known as SETMAR), which resulted from an insertion of the Hsmar1 transposon down‐
stream of a SET gene (suppressor of variegation 3-9, enhancer-of-zeste, trithorax)1 encoding
a histone lysine methyltransferase (HLMT), generating the SET and transposase fusion pro‐
tein [23, 30]. Metnase is not found in prosimian monkeys or other mammals. Presumably
this fusion event has conferred some evolutionary advantage to anthropoid primates as the
activities of both the SET domain and transposase domain have largely been retained.
The Metnase-SET domain comprises pre-SET (aa 14-118), SET (aa 120-256), and post-SET (aa
273-302) domains (Fig. 3). The pre-SET domain contains a cysteine- and histidine-rich puta‐
tive Zn++ binding motif, and the SET domain has the conserved the histone lysine methyl‐
transferase motif shared with other SET proteins in humans [31, 32]. On the other hand, the
Metnase-Transposase domain contains the conserved DNA binding and the catalytic motifs
(Fig. 3). Potential DNA-binding motifs in the Metnase transposase were identified by com‐
parative sequence analysis. These include a Nuclease-associated modular DNA-binding 1
(NUMOD1) motif, residues 417-434 representing a DNA binding helix-turn-helix based on
its similarity to other families [33, 34], and a helix-turn-helix (HTH) motif, residues 347-381
(Fig. 3). Although Metnase cannot perform transposition, it has been shown to retain a num‐
ber of activities associated with transposases including 5’-terminal inverted repeats (TIR)-
specific DNA binding [23, 35-37], DNA looping activity [25], 5’-end processing activity [25,
35, 37], and promotion of integration at a TA dinucleotide target site [25, 38]. Recent struc‐
tural analysis of the Metnase transposase domain has revealed features within the catalytic
site that are distinct from those of related transposases and yet were likely present within
the ancestral Hsmar1 transposase. However, Metnase’s DNA cleavage activity, unlike other
functionally active transposases, is not coupled to its TIR-specific DNA binding [35, 37].
Figure 3. Schematic diagram of human Metnase (SETMAR). The Pre-SET domain contains cysteine- and histidine-rich
putative Zn++ binding motif. The SET domain has the HLMT motif; transposase domain contains DNA binding motifs
[helix-turn-helix (HTH) and NUMOD1] and a conserved DNA cleavage (DDE-like) motif.
Metnase is widely expressed in human tissues promotes NHEJ repair and mediates genomic
integration of foreign DNA [32, 35, 39]. Metnase’s involvement in NHEJ repair came from
an in vivo study showing that overexpression of Metnase increased NHEJ repair, while it
did not produce any significant changes in HR repair [32]. Similarly, cells treated with Met‐
nase-specific siRNA showed a significant reduction in NHEJ repair activity in vivo. Metnase
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overexpression resulted in a 3-fold survival advantage after IR treatment compared to a vec‐
tor control [32], further evidence of a role for Metnase in NHEJ. Metnase is also involved in
genomic integration of foreign DNA [40, 41] that depends on some of the other NHEJ factors
[42, 43]. Earlier study showed that a deletion of either SET or the transposase domain abro‐
gated Metnase’s function in DNA repair, indicating that both domains are required for this
function [40]. Upon DNA damage, Metnase colocalizes with other DSB repair factors and
has been shown to directly interact with Pso4 [34, 36], a human homolog of the 55-kDa pro‐
tein encoded by the PSO4/PRP19 gene in Saccharomyces cerevisiae that has pleiotropic func‐
tions in DNA recombination and error-prone repair [44-47]. Metnase-mediated stimulation
of DNA end joining in vivo requires both histone methyltransferase and transposase-associ‐
ated activities [32], indicating that it has multiple functions in NHEJ repair. The SET-trans‐
posase fusion protein not only promotes DSB repair, but also physically interacts with Topo
IIα and enhances Topo II-mediated chromosomal decatenation [24, 39], both of which are
crucial for controlling DSB damage. Metnase is widely expressed, and is located at chromo‐
some 3p26, a region of frequent abnormalities in various cancers [23, 32]. Metnase is the only
known example of a protein involved in DNA repair that includes a SET domain as well as
the only intact and functional Hsmar1 transposase within the human genome.
3. Histone H3 dimethylation of Lys36 at DSB sites
DSB damage induces post-translational modification of histone proteins at the DNA damage
sites, which not only is necessary for DNA damage sensing but also promotes DNA repair
[48-57]. H2AX, a member of the histone H2A family, is rapidly phosphorylated in response
to ionizing radiation and DNA damaging drug, generating γH2AX [50, 53, 55-57]. Phos‐
phorylation of the histone variant H2AX occurs at the conserved C-terminal phosphatidyli‐
nositol 3-OH-kinase-related kinase (PI3KK) motif, and likely play a key role in DDR and is
required for the assembly of DNA repair proteins at the sites containing damaged chroma‐
tin as well as for activation of checkpoints proteins which arrest the cell cycle progression
[58-61]. DSB damage also induces non-proteolytic ubiquitylation near DNA damage site on
the chromatin. DSB-induced ubiquitination is mediated by the RNF8/RNF168 ubiquitin li‐
gase cascade [60], and has emerged as a key mechanism for restoration of genome integrity
by licensing the DSB-modified chromatin to recruit genome caretaker proteins such as
53BP1 and BRCA1 near the lesions. In parallel, Sumoylation of upstream DSB regulators is
also required for execution of this ubiquitin-dependent chromatin response, although its
molecular basis is not clear.
Histone methylation plays a key role in and as such regulates transcription,  replication,
cell  differentiation, genome stability,  and apoptosis [62-66].  Mounting evidence points to
a  role  for  histone lysine  methylation in  DSB repair  [67-72].  In  mammalian cells,  H3K79
methylation  is  crucial  for  53BP1  localization  at  DSB  sites  and  interaction  with  p53  in
damage  checkpoint  activation  [73].  In  S.  cerevisiae,  loss  of  H3K79  methylation  inhibits
Rad9-dependent  activation  of  the  checkpoint  kinase  Rad53  following  DSB  damage  [74,
75], and in fission yeast controls the recruitment of the damage checkpoint adaptor pro‐
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tein, Crb2 [76-78]. A recent study showed that DSB damage induces dimethylation of his‐
tone H3 at lysine 36 (H3K36me2) in human cells [31, 32]. Chromatin immunoprecipitation
(ChIP)  and  immunoblot  analyses  indicated  that  H3K36me2  is  actually  formed  at  DSB
sites [31]. H3-K36 is associated with chromatin opening [79-84], which may also be a part
of its DSB localization via chromatin modulation. In fact, mutations at known conserved
SET domain amino acids (N210S,  alteration at  the NHSC at  210-213 to  AAAA, and the
YDY  at  247-249  to  AAA)  significantly  lowered  DNA  end  joining  [32].  Two  conserved
amino  acid  sequences  (210-NHSCXPN-216  and 242-EEELXXXY-249)  in  the  Metnase-SET
domain are likely responsible for the interaction with SAM since a mutation at these sites
failed to interact with 3H-labeled SAM [85-88]. Levels of DSB-induced H3K36me2 strong‐
ly correlate with Metnase expression and that the mutant (D248S) lacking HLMT activity
fails  to generate H3K36me2,  suggesting that  Metnase is  responsible for the induction of
H3K36me2 at DSB site [32].  Considering that the D248S mutant of Metnase fails to pro‐
mote NHEJ repair, dimethylation of H3K36 is likely a major function of Metnase in pro‐
moting  chromosomal  DSB  repair.  Although  the  mechanism  by  which  H3K36me2
promotes DSB repair is not clear, H3K36 methylation has been linked to chromatin open‐
ing accessible to transcription regulators and DNA repair proteins [89]. H3K36me2, once
formed at DSB site, may create docking sites for other repair proteins, recruiting them for
transcription and DNA repair.  For  example,  H3K36 methylation attracts  the histone de‐
acetylase Rpd3S, which compact chromatin in the middle of transcribed genes, and inhib‐
its false initiation of transcription during the elongation phase [90]. The methyltransferase
Setd2  (also  known  as  Set2)  mediates  trimethylation  of  H3K36me3  (H3K36me3),  and  it
binds the phosphorylated tail of RNA polymerase II, implicating a role for H3K36me3 in
transcription [49,  51,  91].  Setd2 mediates  H3k36me3 in  mammalian cells,  but  not  di-  or
mono-methylation [92],  raising a possibility that Metnase or other H3K36 dimethyltrans‐
ferases may be necessary to generate H3K36me2 before Setd2 acts. In Drosophila, dimethy‐
lation  of  H3K36  peaks  adjacent  to  promoters  and  requires  distinct  methyltransferases
than those that mediate H3K36me3 [93]. The formation of H3K36me2 might also facilitate
histone eviction at the DSB site, which then facilitates an access of the repair machineries
to DNA damage site.  This is  supported by an observation that H3K36me2 enhances the
presence  of  MRN  complex  and  Ku70  at  the  DSB  site  [31].  These  DNA  repair  proteins
show an increased interaction with H3K36me2 after IR, and their presence at an induced
DSB also correlated with Metnase expression levels. In addition, the chromatin immuno‐
precipitation study revealed that H3K36me2 not only enhances the rate of association of
these  repair  proteins  with  the  DSB but  decreases  their  disassociation rates  as  well  [31].
Because the MRN and Ku complexes can bind free DNA ends at a DSB in nonchromati‐
nized DNA,  the  decreased rates  of  disassociation  are  likely  the  more  important  role  of
H3K36me2. This implies that the main benefit of H3K36me2 in DSB repair is more likely
to stabilize the repair components at the DSB than to enhance their recruitment. It is pos‐
sible that dimethylation of H3K36 at DSBs was an epiphenomenon and was not responsi‐
ble for enhanced localization of early DSB repair components. On the other hand, when a
point mutation at H3-K36 (K36R or K36A) caused a marked decrease in both the recruit‐
ment of NBS1 and Ku70 to the DSB and in DSB repair [31], indicating that H3K36me2 is
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required for efficient assembly and retention of repair components at DSBs and for opti‐
mum DSB repair.  The identification of dimethylated H3K36 as a chromatin modification
that enhances DSB repair  by NHEJ places this modification alongside and ubiquitylated
H2A  as  DNA  damage-induced  histone  modifications  that  recruit  repair  components  to
DSBs and enhance repair [31, 94, 95]. In this regard, H3K36me2 by Metnase is consistent
with an NHEJ histone code, as defined in the original histone code hypothesis for tran‐
scriptional regulation as histone modifications, acting in a combinatorial fashion on histo‐
nes,  which  specify  unique  downstream  functions  [56].  Previous  reports  indicate  that
histone  methylation  may  be  important  in  DNA DSB repair  by  homologous  recombina‐
tion: The DSB repair component 53BP1, which is required for proper homologous recom‐
bination, is recruited to sites of damage by methylated histone H3 lysine 79 (H3K79) and
histone H4 lysine 20 (H4K20) [76, 78, 96].  However, neither H3K79 nor H4K20 methyla‐
tion is induced by DNA damage [96]. H3K36me2 is likely reserved for NHEJ repair path‐
way,  because  Ku70  and  Metnase  are  involved  in  DSB repair  by  NHEJ  rather  than  HR
repair and because the latter requires complete histone eviction adjacent to the DSB. Hu‐
man cancer cells that express Metnase at high levels display enhanced resistance to treat‐
ment with radiation or chemotherapy [32, 131, 132]. The resistance mediated by Metnase
could  reflect  improved  stabilization  of  the  assembly  of  DSB repair  components  at  DSB
sites  due  to  the  generation  of  H3K36me2  at  these  sites.  If  so,  a  targeting  of  Metnase’s
HLMT  activity  may  improve  the  efficacy  of  common  cancer  therapies  based  on  DNA
damaging agents.
4. DNA endonuclease activity in the joining of DSB damage
IR induces DNA double strand breaks with different ends, most of which are not direct‐
ly  ligatable.  Therefore,  they  need  to  be  processed  before  end  joining  event  in  all  three
major  DSB  repair  pathways,  with  the  exception  of  adding  nucleotides  opposite  to  5’-
overhang  by  DNA  polymerase  [97-100].  DNA  end  processing  can  be  divided  into  two
types: ssDNA cleavage that removes either a 5’- or 3’-overhang to leave a blunt end, and
nuclease activity producing a deletion that is consistent with alignment of the DNA ends
by  base  pairing  in  region(s)  of  microhomology  [17,  97,  99,  101].  Several  endonucleases
and their binding partners have been shown to participate in end processing during DSB
repair.  Mre11  and  Artemis  possess  3’-5’  exonuclease  activity  and  ssDNA-specific  5’-3’
exonuclease,  respectively,  both  of  which  may  be  involved  in  promoting  the  joining  of
noncomplementary  ends  via  utilizing  microhomologies  near  the  ends  of  the  DSB  [17,
100,  102-106].  MRN’s  exonuclease  activity  is  for  mismatched  DNA  ends  and  pauses  at
sites  of  microhomology  [100],  while  its  endonuclease  is  to  open  fully  paired  hairpin
DNA [105].  Artemis  possesses  an  endonuclease  activity  specific  for  hairpins  and 5′-  or
3′-overhangs following phosphorylation by DNA-PKcs [17,  106],  suggesting that it  plays
a role in V(D)J  recombination repair  and perhaps in removing the 5′-  and 3′-overhangs
of non-compatible ends during NHEJ repair. Human CtIP physically and functionally in‐
teracting with MRN is another player in DNA end processing [107]. CtIP was originally
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identified as a binding partner for CtBP11 and the tumor suppressor proteins RB1 [108]
and BRCA1 [86,  109],  and is  recruited to  DNA damage and complexes  with  BRCA1 to
control  the  G2/M DNA-damage  checkpoint  [110-112].  CtIP  and the  MRN complex  pro‐
mote  ATR activation  and HR through mediating  DSB resection  [107].  The  Werner  syn‐
drome protein (WRN), a RecQ-like DNA helicase also possesses 3’-5’ exonuclease activity
[42, 43, 113]. Considering that WRN is phosphorylated by DNA-PKcs [113], and its DNA
cleavage activity is stimulated by Ku complex [114], WRN could play a role in DNA end
processing. Other DNA helicases such as Bloom (BLM) and DNA2 may also play a role
in DNA end processing [85].  These two DNA helicases physically interact to each other
to resect DNA in a process that is ATP-dependent and requires BLM helicase and DNA2
nuclease functions [85].  RPA is  essential  for  both DNA unwinding by BLM and enforc‐
ing 5′-3′  resection polarity by DNA2. MRN accelerates processing by recruiting BLM to
the end. In the other, EXO1 resects the DNA and is stimulated by BLM, MRN, and RPA.
BLM increases the affinity of EXO1 for ends, and MRN recruits and enhances the proces‐
sivity of EXO1 [85].
Metnase possesses a unique endonuclease activity that preferentially acts on ssDNA over‐
hang of a partial duplex DNA [35]. Cell extracts lacking Metnase exhibited significantly low‐
ered end joining activity comparable to those seen in extracts lacking DNA-PKcs or Ku80
[35], whereas cell extracts over-expressing Metnase not only stimulated DNA end joining
but also showed an enhanced end processing of non-compatible ends based on DNA se‐
quencing analysis of end joining products [32, 35, 37]. Metnase has no hairpin or loop open‐
ing activity [35], indicating that it does not play a role in V(D)J recombination. Given that
DNA end processing facilitates end joining by increasing the chance for partial annealing
between two non-compatible ends, Metnase’s endonuclease activity may play a direct role
in stimulating DNA end joining through processing of non-compatible ends. While Metnase
contributes to DNA end joining through an enhanced processing of non-compatible ends, its
DNA cleavage activity cannot explain Metnase’s stimulatory role in the joining of compati‐
ble ends [32, 35, 37]. Similar to DNA-PK- and Ku80-defective cells, cell extracts lacking Met‐
nase failed to support joining of compatible ends [32], suggesting that Metnase also has a
role in the joining of compatible ends, perhaps by promoting recruitment of the XRCC4-
DNA ligase 4 (Lig4) complex [115], an essential player in the ligation step through a physical
interaction upon DNA damage. The DNA binding property of Metnase may assist in the lo‐
calization of DNA Lig4 at the free DNA ends. In this case, Metnase is epistatically above
end-processing and subsequent joining, but perhaps below free end recognition and protec‐
tion, in the NHEJ cascade.
One intriguing thing is how a transposase possesses ssDNA overhang cleavage activity in
the absence of TIR sequence. The Metnase-transposase domain has a conserved DDE-like
motif (D483, D575, and N610) that is crucial for DNA cleavage activity (Fig. 3) [35, 37, 116].
The function of residues in the DDE-motif includes coordination of a metal ion required for
catalysis in other transposases. In addition to these residues, several other residues poten‐
tially play a role in the catalytic activity of the transposase domain [116]. Based on the crys‐
tal structure of the Metnase-transposase, the active sites of the two subunits that make up
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the dimer are distinctly different [116]; one subunit has bound metal in the active site and
the other does not [116]. Metal is bound to the active site of one molecule comprising the
dimer coordinated to Asp 483 and Asp 575. Residues K445, R578, and H580 within the cata‐
lytic pocket adopt different conformations in the metal-bound vs. non-metal bound active
site structures and may also play important catalytic functions in ss-overhang cleavage ac‐
tivity. A loop within the active site of Metnase adopts two very different conformations re‐
sulting in a translation of a full residue when superimposed such that Arg 578 is located
within the active site hydrogen-bonded to Glu 484 in the non-metal bound conformation
and flipped out of the active site in the metal bound conformation. Similarly, the position of
His 580 is quite different in each of the two different conformations in our structure. Inter‐
estingly, each conformation of His 580 is hydrogen-bonded to Glu 484. It remains to be seen
what unique feature(s) of the catalytic domain with Metnase is directly linked to its role in
DNA repair and replication fork arrest as compared to traditional transposase function.
5. Metnase binding partners in DSB repair
Metnase is a DNA repair factor colocalized with MRN complex and other repair factors at
the DNA damage sites [36]. On the other hand, it is a transposase that has a capacity to in‐
teract with thousands of potential binding sites (TIR) in human chromosomes [23, 25, 37].
Metnase binds to a specific 19 bp sequence within the consensus Hsmar1 TIR [23, 30, 38,
117]. Similar to other Mariner transposases, the Metnase Helix-Turn-Helix (HTH) motif ac‐
counts for this binding; specifically the R432 residue within the HTH region is essential for
this binding [37]. In human genomes there are a large number of miniature inverted-repeat
transposable elements (MITES). If the solo TIRs are added to the number of MITES, there are
approximately 7,000 potential Metnase binding sites in human genome. How does a trans‐
posase with a sequence-specific DNA binding activity get localized at the DSB sites? A re‐
cent study identified Pso4 as a Metnase binding partner that seems to play a role in Metnase
localization at DSB sites [36]. Although Pso4 is Metnase’s binding partner, coimmunopreci‐
pitation of Metnase and Pso4 also pulled down the human homolog of Spf27, a member of
the Prp19 core complex involved in pre-mRNA splicing [36]. Given that Pso4 is a part of the
pre-mRNA splicing complex consisting of Pso4, Cdc5L, Plrg1, and Spf27 [118], the Metnase-
Pso4 complex may be a part of the bigger complex including other members of the pre-
mRNA splicing complex in vivo. Although the physiologic role of the Metnase-Pso4
interaction is still unclear, cells lacking Pso4 failed to show Metnase localization at the DSB
sites [36], suggesting that Pso4 play a role in the recruitment of Metnase to the DSB sites.
Upon DNA damage, Pso4 is induced [46] and formed a stable complex with Metnase [36]. A
recent biochemical analysis suggested several interesting implications for the architecture of
the Metnase-Pso4 complex on DNA. First, Metnase dimer forms a 1:1 stoichiometric com‐
plex with Pso4 on dsDNA [35, 36]. Although both Metnase and Pso4 can independently in‐
teract with TIR DNA, Pso4 is solely responsible for binding to dsDNA once the two proteins
form a stable complex [35]. This claim is based on the findings that 1) the Metnase-Pso4
complex interacted with same stoichiometric amount of non-TIR DNA as the TIR DNA, 2)
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the Metnase-Pso4 complex interacted with same number of TIR molecules as Metnase or
Pso4 alone did, and 3) formation of the Metnase-TIR complex was significantly inhibited by
excess of TIR and not by non-TIR, whereas the Metnase-Pso4-TIR complexes were equally
inhibited by both TIR and non-TIR DNA [35]. It is possible that Pso4, once forming a com‐
plex with Metnase, may directly interfere with Metnase’s DNA binding domain (helix-turn-
helix motif) [37]. This notion is supported by findings that Metnase bound to TIR DNA went
through a conformational change and was less effective than free Metnase in interacting
with Pso4 [35]. Pso4 has 6 C-terminal WD-40 repeats [119], a module that is known to inter‐
act with post-translationally modified histone 3, including dimethylated-K4 [120]. Given
that Metnase HLMT activity targets H3-K4 as well as H3-K36 [32], it is possible that chroma‐
tin association of Pso4 may occur via Metnase-mediated H3-K4 methylation, while Metnase
requires Pso4 for its DSB localization. Since Pso4 is induced following IR treatment in vivo
[36, 46, 121], formation of a stable Metnase-Pso4 complex likely occurs in response to DNA
damage. The Pso4 also undergoes structural alterations in response to DNA damage [121].
The Metnase-Pso4 complex, once formed, likely goes to nonTIR sites such as DSB sites [36],
since Pso4 is solely responsible for binding to DNA in forming the Metnase-Pso4-DNA com‐
plex. It would be interesting to see whether Pso4 also affects Metnase’s other biochemical
functions such as DNA cleavage activity and HLMT activity. Further structural study would
be necessary to clarify this intriguing issue.
Metnase also physically interacts with DNA ligase IV (Lig4), an essential DSB repair factor
involved in the final end joining step in response to DNA damage [24], which supports the
observations that Metnase promoted joining of both compatible and non-compatible ends
[32, 35]. It remains to be seen whether Metnase plays a direct role in the recruitment of the
XRCC4- Lig4 complex via its interaction with Lig4.
6. Metnase’s role in the replication fork arrest
DNA double-strand breaks can be generated at the replication forks when the replication
machinery encounters a single-strand break (SSB) or other types of DNA adducts. Attempt‐
ed replication past a SSB can generate one-sided DSB which topologically differs from DSBs
introduced by IR (Fig. 4). One-sided DSB is not a natural substrate for NHEJ, so these breaks
can be repaired by homologous recombination repair pathway. Otherwise, it will remain
unrepaired generating chromatid breaks, or it may ligate with a DSB in a different chromo‐
some producing radial chromosomes. Stalled replication forks can also regress to generate a
chicken-foot structure with a double stranded end (Fig. 4). Such a structure is topologically
distinct from IR-induced DSBs in that it encompasses a single double-strand end rather than
two double-strand ends.
Metnase possesses a distinct yet undefined role in the replication stress response [122]. Its
role appears to be limited to restart of stalled and/or collapsed replication forks. DNA repli‐
cation analyses indicated that Metnase promotes cell survival only when cells are subjected
to replication stress such as hydroxyurea (HU), camptothecin (CT), or UV treatment [122].
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Interestingly, when Metnase knockdown cells were treated with HU, the percentage of stop‐
ped forks greatly increased and there was a corresponding large decrease in the percentage
of continuing forks, while new forks were extremely rare in both HU treated and untreated
Metnase knockdown cells [122], indicating that Metnase plays a critical role in restarting
stalled replication forks. It also suggests that Metnase may regulate new origin firing when
cells experience replication stress. Metnase also regulates the efficiency of replication fork
restart, and possibly initiation after replication stress, but it has no effect on the speed of on‐
going forks [122].
Figure 4. Generation of DSB damage and its repair during replication. Replication forks frequently encounter blocks to
their progression including lesions such as single strand breaks. Structures such as a one sided DSB or a chicken-foot
structure generated by fork regression can arise as a consequence of such replication stalling and the available evi‐
dence suggests a major function of HR is to repair or resolve such lesions.
Interestingly, a recent study with poly ADP-ribose polymerase 1 (PARP-1) revealed that it
recruits MRE11 to stalled replication forks [123]. MRE11 with its endonuclease activity may
play a role in processing stalled forks leading to RPA recruitment and eventual restart
through HR . It is possible that Metnase promotes replication fork restart by promoting
NHEJ [124]. NHEJ factors involved in NHEJ are known to promote cell survival after repli‐
cation stress perhaps by facilitating rejoining of DSEs at collapsed forks [125, 126]. Since
each collapsed fork produces only a single broken end that is not a natural substrate for
NHEJ, however, it would be highly inaccurate producing radial chromosomes. Another pos‐
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sibility would be that NHEJ factors promote replication fork restart indirectly through inter‐
actions with HR factors [127]. When replication fork stalls, the initial cellular response is to
stabilize the replisome to prevent fork collapse. Metnase does not appear to play a role in
fork stabilization as similar fractions of cells with collapsed forks were observed regardless
of Metnase expression level [122]. Another mechanism by which Metnase could promote
fork restart is through its interactions with replisome factors including PCNA and RAD9.
Although it is not yet known whether Metnase interacts directly with these proteins, the fact
that the Metnase SET domain has a conserved PIP box is highly suggestive of direct interac‐
tions. Regardless, our results clearly place Metnase at stalled replication fork. The Metnase
SET domain encodes a protein methylase, and Metnase is known to methylate histone H3
and itself [124, 128]. Metnase could regulate PCNA and/or RAD9 function through trans-
methylation, or it could have a more general effect through chromatin modification. In par‐
ticular, Metnase targets histone H3 lysines 4 and 36, which are associated with chromatin
opening, these modifications could enhance repair factor recruitment to stalled or collapsed
forks. Given the well-established role of RAD9 in the intra-S checkpoint response [129], Met‐
nase could promote fork restart by influencing checkpoint activation or downstream check‐
point-dependent processes such as inhibition of origin firing. In addition, Metnase could
affect replication fork restart through its direct interaction with Topoisomerase IIα (Top‐
oIIα). TopoIIα is proposed to relax positive supercoils that form ahead of replication forks
[130]. Currently there is no information about whether supercoils persist in front of stalled
forks. However, when one of the replicative polymerases encounters a blocking lesion, the
other polymerase can become uncoupled and progress for a distance, producing a single-
stranded gap that is bound by RPA, triggering the intra-S checkpoint [129]. This uncoupled
synthesis depends on continued DNA unwinding by the MCM helicase complex, thus posi‐
tive supercoils will continue to accumulate. By promoting TopoIIα-dependent relaxation of
these supercoils, Metnase could help create a favorable topological state that assists in fork
restart. Conceivably, this could involve restart of stalled forks that are processed to a chick‐
en-foot structure since the resolution of such structures is likely dependent on the topologi‐
cal context of the stalled fork. Alternatively, at collapsed forks, the required HR-mediated
invasion of the DSE into the unbroken sister chromatid, require unwinding of the sister du‐
plex and could similarly be affected by the local topological state. Metnase may play differ‐
ent roles depending on the particular state of the stalled or collapsed replication fork.
7. Abnormal expression of Metnase in tumor specimens
The Metnase gene has three exons spread over 13.8 kB located at 3p26, a region of frequent
abnormalities in non-Hodgkin’s lymphoma, acute and chronic lymphocytic leukemia, mye‐
loma, myelodysplasia, hereditary prostate cancer, and breast cancer (http://cgap.nci.nih.gov/
Chromosomes/Mitelman). Metnase is expressed in all human tissues tested to various ex‐
tents (32), with the highest expression in placenta and ovary and the lowest expression in
skeletal muscle, which is reminiscent of expression patterns of other DNA repair proteins
(131). Interestingly, different transcript variants were found in both normal and cancerous
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tissues (23), suggesting that Metnase is broadly expressed and has an important function in
human. Metnase is frequently overexpressed in leukemia and breast cancer cell lines, and
importantly, downregulating Metnase greatly enhances tumor cell sensitivity to common
chemotherapeutics including epididophylotoxins and anthracyclines [132, 133]. Although
the precise mechanism(s) by which Metnase promotes restart of the replication fork, Met‐
nase may be a reasonable target for the therapeutic strategies that block DNA synthesis or
take advantage of inherent defects of tumor cells in replication fork restart [134, 135].
8. Concluding remarks
While transposase accounts for half of the present organization of the human genome, trans‐
posase activity was thought to be extinct in humans probably because unregulated transpo‐
sition would directly affect genomic stability, resulting in an unacceptably high rate of
apoptosis or malignancy [29]. For this reason, transposase functions have been selected
against the mammalian organisms [29], which lead to a generation of the SET-Transposase
chimeric protein termed Metnase with novel functions in DSB repair, replication fork arrest,
and chromosome decatenation that could actually defend the genome against improper
DNA movement or DSB damage (Fig. 5).
Figure 5. Metnase contributes to genome maintenance by promoting DSB repair and chromosome decatenation.
It should be pointed out that there are no other DNA repair proteins in which the DNA
cleavage  and  histone  lysine  methyltransferase  activities  reside  within  the  same protein.
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Although the role(s) of Metnase in DSB repair and other DNA metabolism are yet to be
defined, a deletion of either the SET or the transposase domain abrogated its function in
DNA repair [32], indicating that both domains are essential for this function. Histone ly‐
sine  methyltransferases  (HLMT)  is  a  critical  participant  in  chromatin  integrity  as  evi‐
denced by the number of human diseases including cancers associated with the aberrant
expression of its family members [136]. Although the underlying mechanisms of tumori‐
genesis  are  still  largely  unknown,  Metnase  HLMT targeting  of  H3K36 dimethylation  at
DSB damage sites is not only crucial for damage recognition and the early stage of DSB
repair, but is also of our interest in tumorigenesis [31]. Metnase may thus be a viable an‐
ticancer target  for  a  wide variety of  tumor types.  Given that  altered expression of  Met‐
nase affect joining of both compatible- and non-compatible ends [24, 32, 35, 37], Metnase
likely have two separate functions in the joining of DSB damage: 1) the Metnase-Lig4 in‐
teraction [24] for joining of compatible ends by promoting recruitment of Lig4 complex to
DSB sites, and 2) Metnase’s structure-specific endonuclease for joining of non-compatible
ends by promoting end processing (Fig.  6).  Further  structure-function studies  would be
necessary to  understand how a transposase  becomes an endonuclease  with ss-overhang
cleavage in a TIR-independent manner.
Figure 6. Proposed role(s) for Metnase in DSB repair and chromosome decatenation. Upon DSB damage, the Ku com‐
plex first binds to the DNA ends and recruits DNA-PKcs. Metnase binding partner, Pso4 is induced upon DSB damage,
which, along with the Ku70/80, likely plays a crucial role in Metnase localization at DSB sites. Metnase’s interaction
with Lig4 is also induced upon DSB damage, which promotes joining of compatible ends, while Metnase’s nuclease
activity plays a role in joining of non-compatible ends.
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